Germline polymorphisms of the nod2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment

HIGHLIGHTS

• What: This study explored the molecular mechanisms of particular SNPs highlighting the role of NOD2 in innate immunity and the stress response and its potential impact on RAI efficacy. The study showed a difference between FTC and PTC and was even more clinically relevant. The study showed that the NOD2 rs2066842 polymorphism was linked to a better response to the RAI.
• Who: M. Borowczyk from the Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Przybyszewskiego Street, ‑, Poznan, Poland have published the research: Germline polymorphisms of the NOD2 pathway may predict the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.